S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Adlai Nortye Ltd. [ANL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated17 May 2024 @ 16:00

-4.81% $ 13.25

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China...

Stats
Today's Volume 1 837.00
Average Volume 7 822.00
Market Cap 225.12M
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.830
ATR14 $0.360 (2.72%)
Insider Trading
Date Person Action Amount type
2009-03-16 Blatz Robert G Buy 0
2009-02-18 Blatz Robert G Sell 242 547 Common Stock, par value $.01
2009-02-18 Considine Terry Sell 83 079 Common Stock, par value $.01
2009-02-18 Rhodes Thomas L Sell 92 328 Common Stock, par value $0.01
2008-12-31 Considine Terry Sell 5 000 Common Stock, par value $.01
INSIDER POWER
0.00
Last 97 transactions
Buy: 1 786 556 | Sell: 1 688 226

Adlai Nortye Ltd. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adlai Nortye Ltd. Financials

Annual 2023
Revenue: $5.00M
Gross Profit: $2.78M (55.56 %)
EPS: $-2.42
FY 2023
Revenue: $5.00M
Gross Profit: $2.78M (55.56 %)
EPS: $-2.42
FY 2022
Revenue: $0
Gross Profit: $-2.04M (0.00 %)
EPS: $-0.600

Financial Reports:

No articles found.

Adlai Nortye Ltd. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Adlai Nortye Ltd.

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule EP4 antagonist to modulate the tumor microenvironment; and AN4005, an oral small-molecule PD-L1 inhibitor to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was incorporated in 2018 and is based in Grand Cayman, the Cayman Islands.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators